‘Right Product, Right Time:’ FDA Clears Boston Scientific's Single-Use Duodenoscope
Executive Summary
Amid concerns of infections from duodenoscopes that are not sufficiently re-sterilized, the US FDA has cleared Boston Scientific’s Exalt-D as a the first single-use duodenoscope. Investors expect the device will likely take a significant chunk of the market, especially considering the next competitor is at least a year away.
You may also be interested in...
Boston Scientific Lands NTAP Status For Single-Use Scope
US Medicare’s designation of Boston Scientific’s single-use duodenoscope aims to reduce infections from a popular procedure to treat pancreatic and biliary conditions.
FDA Recommends Broader Use Of Single-Use Bronchoscopes
The single-use scopes should be used in lieu of reprocessed devices when a significant infection risk exists, the US agency says.
VEO Ophthalmics’ Artificial Iris, Boston Scientific’s Single-Use Duodenoscope Win Pass-Through Payments
US CMS described several products winning device pass-through payment status for 2021 in an outpatient prospective payment system final rule.